Publications in collaboration with researchers from Hospital Clinic Barcelona (4)

2025

  1. Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD study

    Experimental Hematology and Oncology, Vol. 14, Núm. 1

2022

  1. MDS-472 STAG2 and SRSF2 Mutations Might Define Prognosis of MDS Patients With Isolated Trisomy 8

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S316-S317

  2. Prognostic impact of micromegakaryocytes in primary myelodysplastic syndromes

    Leukemia and Lymphoma, Vol. 63, Núm. 5, pp. 1227-1235

  3. Response to azacitidine in patients with chronic myelomonocytic leukemia according to overlap myelodysplastic/myeloproliferative neoplasms criteria

    Leukemia Research, Vol. 116